Avestar Capital, LLC Intra Cellular Therapies, Inc. Transaction History

Avestar Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$38.74 - $62.09 $333,164 - $533,974	-8,600 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$35.2 - $53.42 $28,406 - $43,109	-807 Reduced 8.58%	8,600 $450,000
Q3 2021 Nov 09, 2021	SELL	$28.72 - $42.49 $479,336 - $709,158	-16,690 Reduced 63.95%	9,407 $351,000
Q2 2021 Aug 03, 2021	BUY	$29.3 - $44.5 $139,878 - $212,443	4,774 Added 22.39%	26,097 $1.07 Million
Q1 2021 May 03, 2021	BUY	$30.8 - $39.51 $656,748 - $842,471	21,323 New	21,323 $730,000

380

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.